BRIEF-Abbott's Cologuard Plus Receives CE Mark For Colorectal Cancer Screening In Europe

3

Oct 20 (Reuters) – Abbott Laboratories: * ABBOTT'S COLOGUARD PLUS® RECEIVES CE MARK FOR COLORECTAL CANCER SCREENING IN EUROPE Source text: Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)